Form 4: Allovir CFO Vikas Sinha Sells Shares to Cover Tax Obligations

Vikas Sinha, CFO of Allovir, sold 940 shares of common stock on October 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Vikas Sinha, the President and Chief Financial Officer of Allovir, Inc., reported a transaction involving the sale of 940 shares of Allovir common stock on October 3, 2024.
• The sale was executed at a price of $0.8148 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Sinha directly owns 1,152,644 shares of Allovir common stock.
• Sinha may also be deemed to have shared voting and investment power over 16,674,766 shares held by ElevateBio LLC, where he serves as a director and CFO, but he disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates a sale of shares by the CFO to cover tax obligations, which is a common practice.

Stakeholder Impact

• The sale of shares by an insider could have a minor negative impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates